Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 04 entities : Johnson & johnson save search
U.S. $15.98 Billion Cancer Biopsy Markets, 2021-2028: Transition of Novel Oncology Diagnostics from Bench to Clinics & Advancements in Quality and Payment Pertaining to Genetic Cancer Tests
Published: 2021-08-04 (Crawled : 16:00) - prnewswire.com
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.63%
H: 0.26%
C: -1.72%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.11%
H: 0.22%
C: -0.48%
CNMD | $72.64 2.2% 0.0% 500K
|
Health Technology
|
| O: -1.16%
H: 1.4%
C: -3.22%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: -0.35%
H: 0.48%
C: -2.47%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.34%
H: 0.62%
C: -0.07%
CNMD | $72.64 2.2% -1.98% 500K
|
Health Technology
|
| O: -1.16%
H: 1.4%
C: -3.22%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -0.76%
H: 3.32%
C: 1.02%
genetic test cancer diagnostics diagnostic
Iveric Bio Reports Second Quarter 2021 Operational Highlights and Financial Results
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.11%
H: 0.22%
C: -0.48%
ISEE | $39.95 0.38% 0.38% 0
|
Health Technology
|
| O: -0.23%
H: 3.75%
C: -0.91%
financial results results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.